However, total income of the company has decreased by 6.49% at Rs 1997.02 crore for quarter under review as compared to Rs 2135.59 crore for the quarter ended September 30, 2014.
Advertisement
Eros says that direct costs in the current quarter mainly increased because of increase in marketing costs due the mix of films comprised more high and medium budget films, increased amortisation charge as well overflows accrued to co-producers as a result of high performance of films.
Dena Bank posted a fall of 24.85 per cent in its net profit at Rs.38.76 crore during July-September quarter of 2015-16 against Rs.51.58 crore in the year-ago period.
As per the filing, the bank has made a provisioning (other than taxes) of Rs 3,237.39 crore in the second quarter of the fiscal as against Rs 963.43 crore in the year ago period. This compared the to Rs.2,238.50 crore subsidy payout in the second quarter of the last fiscal. During the quarter under review, the net non-performance assets (NPAs) came down to 2.95% at Rs 3,750 crore in the second quarter of FY16 from 3.86% at Rs 4,315.79 crore in the corresponding quarter of last fiscal. Patel added the bank was also not considering any fresh restructuring of loans. The net turnover during the day was Rs. 73344015. EBIDTA during the period was also higher by 29 per cent to Rs 3,442 core against Rs 2,666 crore in H1FY15.
Shares of Sun Pharma today tumbled over 7 per cent to hit its one-year low level after the firm reported a 46 per cent dip in consolidated net profit for the quarter ended September 30.
The total business of the bank during the quarter increased by Rs.9,565 crore, registering a moderate growth of 5.61 per cent. Deposits grew by Rs. 6,531 crore, a rise of 6.22 per cent. Advances saw a growth of 4.62 per cent to Rs. 3,034 crore.
Advertisement
Gross credit stood at Rs 1,51,950 crore.
